17 employees
Northern Biologics use state-of-the-art antibody discovery to tackle novel and challenging targets in oncology and fibrosis.
2014
$7.3M
from 1 investors over 1 rounds
Northern Biologics raised $7.3M on June 28, 2019
Investors: Sixty Degree Capital